not tagged
bayer
['bayer']
data at #asco22 shows ra-223 can be safely given b4 or after psma rlt. mid year we'll commence the alphabet trial combining ra-223 and lu-psma-i&amp;t. 
Working together to improve patient outcomes with personalised medicine: PET/CT, theranostics. Nuclear Medicine Physician ?? Prof ????